Difficulty: Medium
Average Score: 67%
Practice
In the treatment of chronic inflammatory diseases, the most important limitation of aspirin is
Correct answer
C
Rationale
In the treatment of chronic inflammatory diseases, aspirin's most significant limitation is gastric mucosal damage (Option C). This is because aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes, leading to a decrease in prostaglandin synthesis. Prostaglandins play a crucial role in maintaining the integrity of the gastric mucosa by regulating blood flow and promoting mucus production. Inhibition of prostaglandins by aspirin can disrupt the protective barrier of the stomach lining, increasing the risk of gastric ulcers and gastrointestinal bleeding.
Option A (Acid-base and electrolyte disturbances) is not the most important limitation of aspirin in the treatment of chronic inflammatory diseases. While aspirin can cause acid-base and electrolyte disturbances, these are generally less common and severe compared to gastric mucosal damage.
Option B (Hypersensitivity and idiosyncratic reactions) is a potential adverse effect of aspirin but is not its most important limitation in the context of treating chronic inflammatory diseases. Hypersensitivity reactions, including asthma exacerbations and anaphylaxis, are more common in individuals with a known aspirin allergy.
Option D (Salicylism) refers to aspirin toxicity, which can occur with high doses and is characterized by symptoms such as tinnitus, dizziness, and respiratory alkalosis. While salicylism is a concern, it is typically associated with acute overdose rather than the chronic use of aspirin for inflammatory conditions.
In an educational context, understanding the limitations of aspirin is crucial for healthcare professionals to make informed decisions when prescribing NSAIDs for chronic inflammatory diseases. Emphasizing the risk of gastric mucosal damage highlights the need for monitoring patients for gastrointestinal symptoms and considering gastroprotective strategies, such as co-prescribing proton pump inhibitors, to mitigate this potential adverse effect.
Option A (Acid-base and electrolyte disturbances) is not the most important limitation of aspirin in the treatment of chronic inflammatory diseases. While aspirin can cause acid-base and electrolyte disturbances, these are generally less common and severe compared to gastric mucosal damage.
Option B (Hypersensitivity and idiosyncratic reactions) is a potential adverse effect of aspirin but is not its most important limitation in the context of treating chronic inflammatory diseases. Hypersensitivity reactions, including asthma exacerbations and anaphylaxis, are more common in individuals with a known aspirin allergy.
Option D (Salicylism) refers to aspirin toxicity, which can occur with high doses and is characterized by symptoms such as tinnitus, dizziness, and respiratory alkalosis. While salicylism is a concern, it is typically associated with acute overdose rather than the chronic use of aspirin for inflammatory conditions.
In an educational context, understanding the limitations of aspirin is crucial for healthcare professionals to make informed decisions when prescribing NSAIDs for chronic inflammatory diseases. Emphasizing the risk of gastric mucosal damage highlights the need for monitoring patients for gastrointestinal symptoms and considering gastroprotective strategies, such as co-prescribing proton pump inhibitors, to mitigate this potential adverse effect.